Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.49 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.49 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.49 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.49 |
| ▸ | GRM6 | O15303 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL82629 | 0.85 | VCAM1 (0.66) | VCAM1ALDH1A1LMNAGPR35TDP1 | |
| SCHEMBL73860 | 0.84 | VCAM1 (0.70) | VCAM1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL1800029 | 0.82 | GPR35 (0.55) | VCAM1ALDH1A1LMNAGPR35TDP1 | |
| Fluoride SCHEMBL28259583 | 0.82 | VCAM1 (0.68) | VCAM1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL9713754 | 0.82 | MAPT (0.50) | VCAM1ALDH1A1LMNAGPR35TDP1 | |
| SCHEMBL9713702 | 0.82 | VCAM1 (0.46) | VCAM1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL10877621 | 0.81 | MAPT (0.53) | VCAM1ALDH1A1LMNAGPR35TDP1 | |
| SCHEMBL4385438 | 0.81 | VCAM1 (0.61) | VCAM1ALDH1A1TDP1MAPTGRIA1 | |
| SCHEMBL689735 | 0.81 | VCAM1 (0.66) | VCAM1ALDH1A1LMNATDP1SMN1; SMN2 | |
| SCHEMBL3840607 | 0.79 | VCAM1 (0.64) | VCAM1ALDH1A1LMNATDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055236-A1 | POLYETHER NITRILE WITH IMPROVED CRYSTALLIZATION SPEED AND METHOD FOR PRODUCING THE SAME, AND POLYETHER NITRILE RESIN COMPOSITION AND METHOD FOR PRODUCING THE SAME | HONSHU CHEMICAL IND (JP) | 2026-02-26 | — | — | US | disclosed |
| EP-4585635-A1 | POLYETHER NITRILE WITH IMPROVED CRYSTALLIZATION SPEED, METHOD FOR PRODUCING SAME, POLYETHER NITRILE RESIN COMPOSITION, AND METHOD FOR PRODUCING SAME | Honshu Chemical Industry Co., Ltd. (JP) | 2025-07-16 | — | — | EP | disclosed |
| CN-119731238-A | Polyether nitrile having improved crystallization rate and method for producing same, polyether nitrile resin composition and method for producing same | 本州化学工业株式会社 | 2025-03-28 | — | — | CN | disclosed |
| US-20250026886-A1 | METHOD FOR PRODUCING POLYETHER NITRILE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-01-23 | — | — | US | disclosed |
| US-20250019342-A1 | METHOD FOR PRODUCING POLYETHER NITRILE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20250011540-A1 | METHOD FOR PRODUCING POLYETHER NITRILE | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2025-01-09 | — | — | US | disclosed |
| US-12179173-B2 | Functionalized porous organic polymers as uranium nano-traps for efficient uranium extraction | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-12-31 | — | — | US | disclosed |
| EP-4435034-A1 | METHOD FOR PRODUCING POLYETHERNITRILE | Honshu Chemical Industry Co., Ltd. (JP) | 2024-09-25 | — | — | EP | disclosed |
| EP-4435035-A1 | METHOD FOR PRODUCING POLYETHER NITRILE | Honshu Chemical Industry Co., Ltd. (JP) | 2024-09-25 | — | — | EP | disclosed |
| EP-4435033-A1 | PRODUCTION METHOD OF POLYETHER NITRILE | Honshu Chemical Industry Co., Ltd. (JP) | 2024-09-25 | — | — | EP | disclosed |
| US-20060127728-A1 | Membrane-electrode assembly for fuel cell | JSR CORPORATION; and | 2006-06-15 | — | — | US | disclosed |
| US-7053094-B2 | Compositions and methods for treating heart failure | CYTOKINETICS, INC. (US) | 2006-05-30 | — | — | US | disclosed |
| EP-1503986-A4 | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | CYTOKINETICS INC (US) | 2005-11-30 | — | — | EP | disclosed |
| US-20050148638-A1 | Compositions and methods for treating heart failure | CYTOKINETICS, INC. (US) | 2005-07-07 | — | — | US | disclosed |
| US-6908923-B2 | N-(3-oxy-5-functionalphenyl)(hetero)arylcarboxamide derivatives, e.g., 4-fluoro-N-(3-(pyridin-3-yloxy)-phenyl)-benzamide | CYTOKINETICS, INC. (US) | 2005-06-21 | — | — | US | disclosed |
| EP-1524288-A2 | Sulfonated polymer having nitrile-containing hydrophobic block and solid polymer electrolyte | JSR Corporation (JP) | 2005-04-20 | — | — | EP | disclosed |
| US-20050080220-A1 | Sulfonated polymer having nitrile-containing hydrophobic block and solid polymer electrolyte | JSR CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1503986-A2 | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | Cytokinetics, Inc. (US) | 2005-02-09 | — | — | EP | disclosed |
| US-20030158233-A1 | Compositions and methods for treating heart failure | CYTOKINETICS, INCORPORATED | 2003-08-21 | — | — | US | disclosed |
| WO-2003059258-A2 | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | CYTOKINETICS, INC. (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158233-A1 | Compositions and methods for treating heart failure | MYH2, TNNI3, MYLK2 | VCAM1 2898/4885ALDH1A1 3435/4885LMNA 228/4885 |
| US-20260055236-A1 | POLYETHER NITRILE WITH IMPROVED CRYSTALLIZATION SPEED AND METHOD FOR PRODUCING THE SAME, AND POLYETHER NITRILE RESIN COMPOSITION AND METHOD FOR PRODUCING THE SAME | MNS1, RPL7, NOM1 | VCAM1 3405/4885ALDH1A1 4801/4885LMNA 1522/4885 |
| US-20050148638-A1 | Compositions and methods for treating heart failure | MYH2, TNNI3, MYLK2 | VCAM1 2898/4885ALDH1A1 3435/4885LMNA 228/4885 |
| US-20250019342-A1 | METHOD FOR PRODUCING POLYETHER NITRILE | PAH, DBH, NISCH | VCAM1 4800/4885ALDH1A1 1942/4885LMNA 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.